Last reviewed · How we verify

Optimal Dosing of Omeprazole

MetroHealth Medical Center · FDA-approved active Small molecule Quality 2/100

Optimal Dosing of Omeprazole is a Small molecule drug developed by MetroHealth Medical Center. It is currently FDA-approved. Also known as: omeprazole.

At a glance

Generic nameOptimal Dosing of Omeprazole
Also known asomeprazole
SponsorMetroHealth Medical Center
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Optimal Dosing of Omeprazole

What is Optimal Dosing of Omeprazole?

Optimal Dosing of Omeprazole is a Small molecule drug developed by MetroHealth Medical Center.

Who makes Optimal Dosing of Omeprazole?

Optimal Dosing of Omeprazole is developed and marketed by MetroHealth Medical Center (see full MetroHealth Medical Center pipeline at /company/metrohealth-medical-center).

Is Optimal Dosing of Omeprazole also known as anything else?

Optimal Dosing of Omeprazole is also known as omeprazole.

What development phase is Optimal Dosing of Omeprazole in?

Optimal Dosing of Omeprazole is FDA-approved (marketed).

Related